Fairmount Healthcare Fund Ii L.P.
Director at Crescent Biopharma, Inc. (CBIO); Director at Viridian Therapeutics, Inc.\DE (VRDN)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return+34.8%
vs. S&P 500+30.7%
Beat the market100%
Paper profit on buys+$2.3M
Total bought / sold$32.4M / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 20SEC | CBIOCrescent Biopharma, Inc. | Buy | 853,4503,601,316 held (+31%) | $14.50 | $12.4M | +2.8% |
| May 13SEC | VRDNViridian Therapeutics, Inc.\DE | Buy | 1,176,4705,090,928 held (+30%) | $17.00 | $20.0M | +9.8% |
- Buy
Director Fairmount Healthcare Fund Ii L.P. bought $12.4M of CBIO at $14.50 — first open-market purchase in our records; raises the stake by 31%.
- Buy
Director Fairmount Healthcare Fund Ii L.P. bought $20.0M of VRDN at $17.00 — first open-market purchase in our records; raises the stake by 30%.